Wikisage, the free encyclopedia of the second generation, is digital heritage
Bezafibrate: Difference between revisions
Jump to navigation
Jump to search
(→ATC: template) |
(→ATC) |
||
| Line 21: | Line 21: | ||
|} | |} | ||
{{refs}} | |||
{{Wikidata|Q577387}} | {{Wikidata|Q577387}} | ||
[[Category:Hepatotoxic substances]] | [[Category:Hepatotoxic substances]] | ||
Latest revision as of 23:14, 26 February 2019
Bezafibrate was originally developed as a drug for treatment of hyperlipidemia and used for the prevention of cardiovascular diseases. This fibrate reduces triglyceride and rises HDL-cholesterol[1][2]
ursodeoxycholic acid and bezafibrate are under study in the treatment of biliar cirrhosis (See Figure in gallery).
Links
Ginseng, green tea or fibrate: valid options for nonalcoholic steatohepatitis prevention?
ATC
Lipid modifying agents
